All Stories

  1. Increased circulating T helper 17 (TH17) cells and endometrial tissue IL-17-producing cells in patients with endometriosis compared with non-endometriotic subjects
  2. Nanoparticle-mediated enhancement of DNA Vaccines: Revolutionizing immunization strategies
  3. Bispecific Antibodies in Targeted Cancer Immunotherapy
  4. The Role of Inflammasome in Cancers and Potential Therapeutic Targets
  5. Identification of placenta-specific protein 1 (PLAC-1) expression on human PC-3 cell line-derived prostate cancer stem cells compared to the tumor parental cells
  6. Current and future immunotherapeutic approaches in pancreatic cancer treatment
  7. Vitamin D and reproductive disorders: a comprehensive review with a focus on endometriosis
  8. Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma
  9. Cancer Immunotherapies Targeting Cancer Stem Cells: Concepts, Applications, and Advances
  10. The effects of Ellagic acid supplementation on neurotrophic, inflammation, and oxidative stress factors, and indoleamine 2, 3-dioxygenase gene expression in multiple sclerosis patients with mild to moderate depressive symptoms: A randomized, triple-bli...
  11. Ellagic acid effects on disease severity, levels of cytokines and T-bet, RORγt, and GATA3 genes expression in multiple sclerosis patients: a multicentral-triple blind randomized clinical trial
  12. One pediatrician's battle with COVID-19 and acute liver failure
  13. Bispecific antibodies targeting CTLA-4: game-changer troopers in cancer immunotherapy
  14. SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy
  15. The association between CD3+ and CD8+tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic adenocarcinoma
  16. Indoleamine 2,3-Dioxygenase (IDO) and Cancerous Cells
  17. Bispecific Antibodies in Targeted Cancer Immunotherapy
  18. Current Clinical Landscape of Immunotherapeutic Approaches in Pancreatic Cancer Treatment
  19. The Role of Inflammasome in Cancers and Potential Therapeutic Targets
  20. Unleashing the Potential of Natural Killer Cells in Immunotherapy for Glioblastoma and Brain Tumors
  21. Complement system as the potential therapeutic target in the management of COVID-19 patients
  22. Tumor-promoting myeloid cells in the pathogenesis of human oncoviruses: potential targets for immunotherapy
  23. Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectives
  24. Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials
  25. Body mass index and endometriosis: Is there a relationship?
  26. Acute Liver Failure in a Pediatrician with COVID-19: a Case Report
  27. The Role of Intra-Tumor Hypoxia in Cancer Cells Immune Escape Mechanism
  28. Immunological Tolerance
  29. The molecular mechanisms and therapeutic potential of EZH2 in breast cancer
  30. Potential Antiviral Immune Response Against COVID-19: Lessons Learned from SARS-CoV
  31. Death due to COVID‐19 in a patient with diabetes, epilepsy, and gout comorbidities
  32. Death due to Covid-19 in a Patient with Diabetes, Epilepsy, and Gout comorbidities